Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 81
Filter
1.
J Immunol ; 207(3): 974-984, 2021 08 01.
Article in English | MEDLINE | ID: mdl-34282000

ABSTRACT

K9CATH is the sole cathelicidin in canines (dogs) and exhibits broad antimicrobial activity against both Gram-positive and Gram-negative bacteria. K9CATH also modulates inflammatory responses and binds to LPS. These activities depend on the secondary structure and a net-positive charge of the peptide. Peptidylarginine deiminases (PAD) convert cationic peptidyl arginine to neutral citrulline. Thus, we hypothesized that citrullination is a biologically relevant modification of the peptide that would reduce the antibacterial and LPS-binding activities of K9CATH. Recombinant PAD2 and PAD4 citrullinated K9CATH to various extents and circular dichroism spectroscopy revealed that both native and citrullinated K9CATH exhibited similar α-helical secondary structures. Notably, citrullination of K9CATH reduced its bactericidal activity, abolished its ability to permeabilize the membrane of Gram-negative bacteria and reduced the hemolytic capacity. Electron microscopy showed that citrullinated K9CATH did not cause any morphological changes of Gram-negative bacteria, whereas the native peptide caused clear alterations of membrane integrity, concordant with a rapid bactericidal effect. Finally, citrullination of K9CATH impaired its capacity to inhibit LPS-mediated release of proinflammatory molecules from mouse and canine macrophages. In conclusion, citrullination attenuates the antibacterial and the LPS-binding properties of K9CATH, demonstrating the importance of a net positive charge for antibacterial lysis of bacteria and LPS-binding effects and suggests that citrullination is a means to regulate cathelicidin activities.


Subject(s)
Anti-Bacterial Agents/metabolism , Anti-Inflammatory Agents/metabolism , Antimicrobial Cationic Peptides/metabolism , Escherichia coli Infections/immunology , Escherichia coli/physiology , Macrophages/immunology , Pasteurella Infections/metabolism , Pasteurella multocida/physiology , Protein-Arginine Deiminases/metabolism , Animals , Anti-Bacterial Agents/chemistry , Anti-Inflammatory Agents/chemistry , Antimicrobial Cationic Peptides/chemistry , Citrullination , Dogs , Immunity, Innate , Inflammation Mediators/metabolism , Lipopolysaccharides/metabolism , Mice , Protein Binding , RAW 264.7 Cells , Cathelicidins
2.
Vet Res ; 52(1): 37, 2021 Mar 04.
Article in English | MEDLINE | ID: mdl-33663572

ABSTRACT

Fowl cholera caused by Pasteurella multocida exerts a massive economic burden on the poultry industry. Lipopolysaccharide (LPS) is essential for the growth of P. multocida genotype L1 strains in chickens and specific truncations to the full length LPS structure can attenuate bacterial virulence. Here we further dissected the roles of the outer core transferase genes pcgD and hptE in bacterial resistance to duck serum, outer membrane permeability and virulence in ducks. Two P. multocida mutants, ΔpcgD and ΔhptE, were constructed, and silver staining confirmed that they all produced truncated LPS profiles. Inactivation of pcgD or hptE did not affect bacterial susceptibility to duck serum and outer membrane permeability but resulted in attenuated virulence in ducks to some extent. After high-dose inoculation, ΔpcgD showed remarkably reduced colonization levels in the blood and spleen but not in the lung and liver and caused decreased injuries in the spleen and liver compared with the wild-type strain. In contrast, the ΔhptE loads declined only in the blood, and ΔhptE infection caused decreased splenic lesions but also induced severe hepatic lesions. Furthermore, compared with the wild-type strain, ΔpcgD was significantly attenuated upon oral or intramuscular challenge, whereas ΔhptE exhibited reduced virulence only upon oral infection. Therefore, the pcgD deletion caused greater virulence attenuation in ducks, indicating the critical role of pcgD in P. multocida infection establishment and survival.


Subject(s)
Bacterial Proteins/genetics , Pasteurella Infections/veterinary , Pasteurella multocida/physiology , Pasteurella multocida/pathogenicity , Poultry Diseases/microbiology , Transferases/genetics , Animals , Bacterial Proteins/metabolism , Ducks , Lipopolysaccharides/metabolism , Pasteurella Infections/microbiology , Pasteurella multocida/genetics , Transferases/metabolism
3.
Vet Res ; 51(1): 140, 2020 Nov 23.
Article in English | MEDLINE | ID: mdl-33225994

ABSTRACT

Pasteurella (P.) multocida is a zoonotic pathogen, which is able to cause respiratory disorder in different hosts. In cattle, P. multocida is an important microorganism involved in the bovine respiratory disease complex (BRDC) with a huge economic impact. We applied air-liquid interface (ALI) cultures of well-differentiated bovine airway epithelial cells to analyze the interaction of P. multocida with its host target cells. The bacterial pathogen grew readily on the ALI cultures. Infection resulted in a substantial loss of ciliated cells. Nevertheless, the epithelial cell layer maintained its barrier function as indicated by the transepithelial electrical resistance and the inability of dextran to get from the apical to the basolateral compartment via the paracellular route. Analysis by confocal immunofluorescence microscopy confirmed the intactness of the epithelial cell layer though it was not as thick as the uninfected control cells. Finally, we chose the bacterial neuraminidase to show that our infection model is a sustainable tool to analyze virulence factors of P. multocida. Furthermore, we provide an explanation, why this microorganism usually is a commensal and becomes pathogenic only in combination with other factors such as co-infecting microorganisms.


Subject(s)
Bovine Respiratory Disease Complex/microbiology , Pasteurella Infections/veterinary , Pasteurella multocida/physiology , Respiratory System/microbiology , Animals , Cattle , Epithelial Cells/microbiology , Host-Pathogen Interactions , Pasteurella Infections/microbiology
4.
BMC Genomics ; 20(1): 63, 2019 Jan 18.
Article in English | MEDLINE | ID: mdl-30658579

ABSTRACT

BACKGROUND: Pasteurella multocida (P. multocida) is a widespread opportunistic pathogen that infects human and various animals. Genomic Islands (GIs) are one of the most important mobile components that quickly help bacteria acquire large fragments of foreign genes. However, the effects of GIs on P. multocida are unknown in the evolution of bacterial populations. RESULTS: Ten avian-sourced P. multocida obtained through high-throughput sequencing together with 104 publicly available P. multocida genomes were used to analyse their population genetics, thus constructed a pan-genome containing 3948 protein-coding genes. Through the pan-genome, the open evolutionary pattern of P. multocida was revealed, and the functional components of 944 core genes, 2439 accessory genes and 565 unique genes were analysed. In addition, a total of 280 GIs were predicted in all strains. Combined with the pan-genome of P. multocida, the GIs accounted for 5.8% of the core genes in the pan-genome, mainly related to functional metabolic activities; the accessory genes accounted for 42.3%, mainly for the enrichment of adaptive genes; and the unique genes accounted for 35.4%, containing some defence mechanism-related genes. CONCLUSIONS: The effects of GIs on the population genetics of P. multocida evolution and adaptation to the environment are reflected by the proportion and function of the pan-genome acquired from GIs, and the large quantities of GI data will aid in additional population genetics studies.


Subject(s)
Genome, Bacterial/genetics , Genomic Islands/genetics , Pasteurella multocida/genetics , Symbiosis/genetics , Animals , Genes, Bacterial/genetics , Genetics, Population , Genomics/methods , Humans , Pasteurella Infections/microbiology , Pasteurella multocida/classification , Pasteurella multocida/physiology , Phylogeny , Species Specificity
5.
Microb Pathog ; 127: 257-266, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30550841

ABSTRACT

Pasteurella multocida causes respiratory infectious diseases in a multitude of birds and mammals. A number of virulence-associated genes were reported across different strains of P. multocida, including those involved in the iron transport and metabolism. Comparative iron-associated genes of P. multocida among different animal hosts towards their interaction networks have not been fully revealed. Therefore, this study aimed to identify the iron-associated genes from core- and pan-genomes of fourteen P. multocida strains and to construct iron-associated protein interaction networks using genome-scale network analysis which might be associated with the virulence. Results showed that these fourteen strains had 1587 genes in the core-genome and 3400 genes constituting their pan-genome. Out of these, 2651 genes associated with iron transport and metabolism were selected to construct the protein interaction networks and 361 genes were incorporated into the iron-associated protein interaction network (iPIN) consisting of nine different iron-associated functional modules. After comparing with the virulence factor database (VFDB), 21 virulence-associated proteins were determined and 11 of these belonged to the heme biosynthesis module. From this study, the core heme biosynthesis module and the core outer membrane hemoglobin receptor HgbA were proposed as candidate targets to design novel antibiotics and vaccines for preventing pasteurellosis across the serotypes or animal hosts for enhanced precision agriculture to ensure sustainability in food security.


Subject(s)
Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Iron/metabolism , Pasteurella multocida/genetics , Protein Interaction Maps , Biological Transport , Metabolic Networks and Pathways/genetics , Pasteurella multocida/physiology , Protein Binding , Virulence
6.
Arch Microbiol ; 201(6): 833-840, 2019 Aug.
Article in English | MEDLINE | ID: mdl-30955056

ABSTRACT

Bacterial respiratory infections affecting pigs such as pneumonia, pleuropneumonia, and pleurisy, are a major health concern in the swine industry and are associated with important economic losses. This study aimed to investigate the antibacterial activities of essential oils against major swine respiratory pathogens with a view to developing a potential alternative to antibiotics. Their synergistic interactions with the bacteriocin nisin was also examined. Lastly, we assessed the in vitro biocompatibility of the most efficient essential oils using a pig tracheal epithelial cell line. Of the nine essential oils tested, those from cinnamon, thyme, and winter savory were the most active against Streptococcus suis, Actinobacillus pleuropneumoniae, Actinobacillus suis, Bordetella bronchiseptica, Haemophilus parasuis, and Pasteurella multocida, with minimum inhibitory concentrations and minimum bactericidal concentrations ranging from 0.01 to 0.156% (v/v). The main component found in cinnamon, thyme, and winter savory oils were cinnamaldehyde, thymol, and carvacrol, respectively. Treating pre-formed S. suis and A. pleuropneumoniae biofilms with thyme or winter savory oils significantly decreased biofilm viability. We also observed a synergistic growth inhibition of S. suis with mixtures of nisin and essential oils from thyme and winter savory. Concentrations of nisin and cinnamon, thyme and winter savory essential oils that were effective against bacterial pathogens had no effect on the viability of pig tracheal epithelial cells. The present study brought evidence that essential oils are potential antimicrobial agents against bacteria associated with porcine respiratory infections.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Bacterial Infections/veterinary , Oils, Volatile/pharmacology , Plant Oils/pharmacology , Respiratory Tract Diseases/veterinary , Swine Diseases/microbiology , Animals , Anti-Bacterial Agents/chemistry , Bacterial Infections/microbiology , Bacterial Physiological Phenomena , Biofilms/drug effects , Cinnamomum zeylanicum/chemistry , Cymenes , Microbial Sensitivity Tests , Monoterpenes/pharmacology , Nisin/pharmacology , Oils, Volatile/chemistry , Pasteurella multocida/drug effects , Pasteurella multocida/physiology , Plant Oils/chemistry , Respiratory Tract Diseases/microbiology , Satureja/chemistry , Streptococcus suis/drug effects , Streptococcus suis/physiology , Swine , Thymus Plant/chemistry
7.
J Dairy Sci ; 102(12): 11359-11369, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31548072

ABSTRACT

The primary objective of this randomized controlled challenge study was to investigate the effect of ampicillin on ultrasonographic (US) lung consolidation after experimental challenge with Pasteurella multocida in preweaned dairy calves. The secondary objectives were to determine whether ampicillin affected respiratory score, gross consolidation, or the detection of P. multocida in lung tissue at postmortem exam (PME). Holstein bull calves (n = 39) were transported to the University of Wisconsin-Madison School of Veterinary Medicine isolation facility at the mean (±SD) age of 52 ± 6 d. After a 7-d acclimation period, 30 calves were inoculated intratracheally with 1010 cfu of ampicillin-sensitive P. multocida. Lung US and respiratory scoring were performed 2, 6, 12, and 24 h post-challenge, then US once daily and respiratory scoring twice daily until d 14. Calves were randomized to receive ampicillin [n = 17, treatment (TX), 6.6 mg/kg i.m. once daily for 3 d] or placebo [n = 11, control (CON), saline, equal volume, i.m. once daily for 3 d] when ≥1 cm2 of lung consolidation was observed and ≥6 h had elapsed since challenge. Lung lesions ≥1 cm2 were considered positive for consolidation. Calves were respiratory score positive if ≥2 in 2 or more categories based on the Wisconsin respiratory health score chart. Area under the curve (AUC) was calculated for US score and respiratory score as a proxy for time with consolidation and clinical respiratory disease, respectively. Gross lung lesions and pathogens were quantified following PME. At the time of first treatment, consolidation had developed in 28/30 calves (TX, n = 17; CON, n = 11) and 6% (1 out of 17) of TX and 9% (1 out of 11) of CON calves had a positive respiratory score. The TX calves had a significantly lower median (interquartile range given in parentheses) AUC for US score [TX: 23 (20, 29), CON: 47 (33, 53)], whereas mean AUC for respiratory score was not different between groups (TX: 93 ± 28, CON: 96 ± 17). On d 14, 70% (12 out of 17) of TX and 100% (11 out of 11) of CON calves had lung consolidation, and 24% (4 out of 17) of TX and 27% (3 out of 11) of CON calves had clinical respiratory disease. On PME, median consolidation was 10% (6, 15) for TX and 10% (2, 28) for CON calves. Lung cultures were positive for P. multocida in 77% (13 out of 17) of TX and 91% (10 out of 11) of CON calves. Lung health benefited from a 3-d ampicillin therapy, but benefits were short-lived. Treatment failures might be due to incomplete resolution of the initial lung infection. Future studies are needed to optimize TX strategies to improve long-term lung health.


Subject(s)
Ampicillin/administration & dosage , Anti-Bacterial Agents/administration & dosage , Cattle Diseases/drug therapy , Lung Diseases/veterinary , Pasteurella multocida/physiology , Respiratory Tract Diseases/veterinary , Animals , Cattle , Cattle Diseases/microbiology , Lung/microbiology , Lung Diseases/drug therapy , Lung Diseases/microbiology , Male , Random Allocation , Respiratory Tract Diseases/drug therapy , Respiratory Tract Diseases/microbiology
8.
Lett Appl Microbiol ; 67(3): 244-253, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29808940

ABSTRACT

Currently used alum precipitated and oil adjuvant vaccines against HS caused by Pasteurella multocida B:2, have side effects and short-lived immunity, leading to regular catastrophic outbreaks in bovines in Asian subcontinent. The need for the development of an improved vaccine with longer immunity and the ability to differentiate between vaccinated and infected is essential. Pasteurella phage isolated in present study belongs to family Siphoviridae. PMP-GAD-IND phage exhibited lytic activity against vaccine strain (P52) as well as several field strains of P. multocida (B:2), and fowl cholera agent (P. multocida A:1).The phage has a double stranded DNA (dsDNA) with a genome of 46 335 bp. The complete genome sequence of the Pasteurella multocida phage has been deposited in Gen Bank with accession no: KY203335. PMP-GAD-IND being a lytic phage with broad activity range has a potential to be used in therapy against multidrug resistant P. multocida infections. SIGNIFICANCE AND IMPACT OF THE STUDY: The present work is a part of research for the development of an improved phage lysate marker vaccine and a companion DIVA assay against haemorhagic septicaemia. This study describes the isolation and genome analysis of PMP-GAD-IND a lytic Pasteurella multocida bacteriophage.


Subject(s)
Bacteriophages/isolation & purification , Cattle Diseases/microbiology , Genome, Viral , Hemorrhagic Septicemia/veterinary , Pasteurella multocida/virology , Siphoviridae/isolation & purification , Animals , Bacteriophages/classification , Bacteriophages/genetics , Bacteriophages/physiology , Cattle , Genome Size , Hemorrhagic Septicemia/microbiology , Pasteurella multocida/isolation & purification , Pasteurella multocida/physiology , Siphoviridae/classification , Siphoviridae/genetics , Siphoviridae/physiology
9.
BMC Vet Res ; 13(1): 186, 2017 Jun 19.
Article in English | MEDLINE | ID: mdl-28629460

ABSTRACT

BACKGROUND: Pasteurella multocida B:2 causes bovine haemorrhagic septicaemia (HS), leading to rapid fatalities in cattle and buffaloes. An attenuated derivative of P. multocida B:2 GDH7, was previously constructed through mutation of the gdhA gene and proved to be an effective live attenuated vaccine for HS. Currently, only two potential live attenuated vaccine candidates for HS are being reported; P. multocida B:2 GDH7 and P. multocida B:2 JRMT12. This study primarily aims to investigate the potential of P. multocida B:2 GDH7 strain as a delivery vehicle for DNA vaccine for future multivalent applications. RESULTS: An investigation on the adherence, invasion and intracellular survival of bacterial strains within the bovine aortic endothelial cell line (BAEC) were carried out. The potential vaccine strain, P. multocida B:2 GDH7, was significantly better (p ≤ 0.05) at adhering to and invading BAEC compared to its parent strain and to P. multocida B:2 JRMT12 and survived intracellularly 7 h post treatment, with a steady decline over time. A dual reporter plasmid, pSRGM, which enabled tracking of bacterial movement from the extracellular environment into the intracellular compartment of the mammalian cells, was subsequently transformed into P. multocida B:2 GDH7. Intracellular trafficking of the vaccine strain, P. multocida B:2 GDH7 was subsequently visualized by tracking the reporter proteins via confocal laser scanning microscopy (CLSM). CONCLUSIONS: The ability of P. multocida B:2 GDH7 to model bactofection represents a possibility for this vaccine strain to be used as a delivery vehicle for DNA vaccine for future multivalent protection in cattle and buffaloes.


Subject(s)
Bacterial Vaccines , Cattle Diseases/prevention & control , Endothelium, Vascular/microbiology , Hemorrhagic Septicemia/veterinary , Pasteurella multocida/physiology , Animals , Aorta/cytology , Aorta/microbiology , Bacterial Adhesion , Bacterial Vaccines/genetics , Bacterial Vaccines/toxicity , Cattle , Cattle Diseases/microbiology , Cells, Cultured , Hemorrhagic Septicemia/prevention & control , Pasteurella multocida/genetics , Vaccines, Attenuated/genetics , Vaccines, Attenuated/toxicity , Vaccines, DNA/toxicity
10.
Biofouling ; 33(1): 14-23, 2017 01.
Article in English | MEDLINE | ID: mdl-27892689

ABSTRACT

Pasteurella multocida (Pm) is the causative agent of atrophic rhinitis in swine. This study aimed to discover biofilm inhibitors against swine Pm to counteract antibiotic resistance and decrease virulence. The virulence factor outer membrane protein A (OmpA) was targeted. A library of drugs approved by the Food and Drug Administration (FDA) was used to perform virtual screening against PmOmpA. The top-scoring compounds had no effect on the growth of Pm serotype A or D. Mycophenolate mofetil showed the highest efficacy in inhibiting biofilm formation by Pm serotype A, with an IC50 of 7.3 nM. For Pm serotype D, indocyanine green showed the highest effect at an IC50 of 11.7 nM. Nevertheless, these compounds had no effect on an established biofilm of Pm. This study offers an alternative way to prevent biofilm formation by Pm that could also be applied to other pathogens.


Subject(s)
Bacterial Outer Membrane Proteins/antagonists & inhibitors , Biofilms/drug effects , Indocyanine Green/pharmacology , Mycophenolic Acid/pharmacology , Pasteurella Infections/microbiology , Pasteurella multocida/drug effects , Rhinitis, Atrophic/microbiology , Amino Acid Sequence , Animals , Bacterial Outer Membrane Proteins/chemistry , Bacterial Outer Membrane Proteins/genetics , Biofilms/growth & development , Models, Biological , Models, Molecular , Pasteurella Infections/drug therapy , Pasteurella multocida/metabolism , Pasteurella multocida/pathogenicity , Pasteurella multocida/physiology , Protein Binding , Rhinitis, Atrophic/drug therapy , Swine , Virulence , Virulence Factors/metabolism
11.
Am J Physiol Lung Cell Mol Physiol ; 311(2): L389-99, 2016 08 01.
Article in English | MEDLINE | ID: mdl-27343192

ABSTRACT

The incidence of empyema (EMP) is increasing worldwide; EMP generally occurs with pleural loculation and impaired drainage is often treated with intrapleural fibrinolytic therapy (IPFT) or surgery. A number of IPFT options are used clinically with empiric dosing and variable outcomes in adults. To evaluate mechanisms governing intrapleural fibrinolysis and disease outcomes, models of Pasteurella multocida and Streptococcus pneumoniae were generated in rabbits and the animals were treated with either human tissue (tPA) plasminogen activator or prourokinase (scuPA). Rabbit EMP was characterized by the development of pleural adhesions detectable by chest ultrasonography and fibrinous coating of the pleura. Similar to human EMP, rabbits with EMP accumulated sizable, 20- to 40-ml fibrinopurulent pleural effusions associated with extensive intrapleural organization, significantly increased pleural thickness, suppression of fibrinolytic and plasminogen-activating activities, and accumulation of high levels of plasminogen activator inhibitor 1, plasminogen, and extracellular DNA. IPFT with tPA (0.145 mg/kg) or scuPA (0.5 mg/kg) was ineffective in rabbit EMP (n = 9 and 3 for P. multocida and S. pneumoniae, respectively); 2 mg/kg tPA or scuPA IPFT (n = 5) effectively cleared S. pneumoniae-induced EMP collections in 24 h with no bleeding observed. Although intrapleural fibrinolytic activity for up to 40 min after IPFT was similar for effective and ineffective doses of fibrinolysin, it was lower for tPA than for scuPA treatments. These results demonstrate similarities between rabbit and human EMP, the importance of pleural fluid PAI-1 activity, and levels of plasminogen in the regulation of intrapleural fibrinolysis and illustrate the dose dependency of IPFT outcomes in EMP.


Subject(s)
Empyema, Pleural/drug therapy , Fibrinolytic Agents/administration & dosage , Pasteurella Infections/drug therapy , Pneumococcal Infections/drug therapy , Thrombolytic Therapy , Tissue Plasminogen Activator/administration & dosage , Urokinase-Type Plasminogen Activator/administration & dosage , Animals , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Empyema, Pleural/diagnostic imaging , Empyema, Pleural/microbiology , Female , Humans , Pasteurella Infections/microbiology , Pasteurella multocida/physiology , Pleura/diagnostic imaging , Pleura/microbiology , Pleura/pathology , Pneumococcal Infections/microbiology , Rabbits , Recombinant Proteins/administration & dosage , Streptococcus pneumoniae/physiology
12.
Microb Pathog ; 93: 111-9, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26850845

ABSTRACT

Haemorrhagic septicaemia (HS) is an acute, fatal, septicaemic disease of cattle and buffaloes caused by one of two specific serotypes of Pasteurella multocida B:2 and E:2 in Asian and African, respectively. It is well known that HS affect mainly the respiratory and digestive tracts. However, involvement of the nervous system in pathogenesis of HS has been reported in previous studies without details. In this study, nine buffalo calves of 8 months old were distributed into three groups. Animals of Group 1 and 2 were inoculated orally and subcutaneously with 10 ml of 1 × 10(12) cfu/ml of P. multocida B:2, respectively, while animals of Group 3 were inoculated orally with 10 ml of phosphate buffer saline as a control. All calves in Group 1 and Group 3 were euthanised after 504 h (21 day) post-infection, while calves in Group 2 had to euthanise after 12 h post-infection as they develop sever clinical signs of HS. Significant differences were found in Group 2 in the mean scores of clinical signs, gross and histopathological changes which mainly affect different anatomic regions of the nervous system. In addition, successful bacterial isolation of P. multocida B:2 were obtained from different sites of the nervous system. On the other hand, less sever, clinical, gross and histopathological changes were found in Group 1. These results provide for the first time strong evidence of involving of the nervous system in pathogenesis of HS, especially in the peracute stage of the disease.


Subject(s)
Buffaloes/parasitology , Hemorrhagic Septicemia/veterinary , Nervous System/parasitology , Pasteurella multocida/physiology , Animals , Cattle , Female , Hemorrhagic Septicemia/parasitology , Hemorrhagic Septicemia/pathology , Male , Nervous System/pathology , Pasteurella multocida/genetics , Pasteurella multocida/isolation & purification
13.
Microb Pathog ; 91: 141-54, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26706347

ABSTRACT

Haemorrhagic septicaemia is a disease caused by Pasteurella multocida serotype B: 2 and E: 2. The organism causes acute, highly fatal septicaemic disease with high morbidity and mortality in cattle and more susceptible in buffaloes. Lipopolysaccharide can be found on the outer cell wall of the organism. Lipopolysaccharide is released during multiplication which leads to inflammatory reaction. It represents the endotoxin of P. multocida type B: 2 and responsible for toxicity in haemorrhagic septicaemia which plays an important role in the pathogenesis of the disease. Therefore, the aim of this study was to investigate the clinical signs, blood parameters, gross post mortem lesions and histopathology changes caused by P. multocida type B:2 immunogen lipopolysaccharide infections initiated through intravenous and oral routes of infection. 9 buffalo heifers were divided equally into 3 treatment groups. Group 1 was inoculated orally with 10 ml of phosphate buffer saline (PBS); Group 2 and 3 were inoculated with 10 ml of lipopolysaccharide broth intravenously and orally respectively. For the clinical signs, there were significant differences (p < 0.05) in temperature between the control, intravenous and oral group. In hematology and biochemistry findings, there were significant differences (p < 0.05) in erythrocytes, haemoglobin, PCV, MCV, lymphocytes, monocytes, eosinophils, GGT and albumin between the control, intravenous and oral group. However, there were no significant differences (p > 0.05) in the MCHC, leukocytes, band neutrophils, basophils, thrombocytes, plasma protein, icterus index, total protein, globulin and A:G ratio between intravenous and oral group. For Group 2 buffaloes, there were gross lesions in the lung, trachea, heart, liver, spleen, and kidney. In contrast, lesions were only observed in the lung, trachea and liver of Group 3 buffaloes. There were significant differences (p < 0.05) in hemorrhage and congestion; necrosis and degeneration; and inflammatory cells infiltration between experimental groups and control group. However, there were no significant differences (p > 0.05) in edema lesion between groups. In conclusion, this study is a proof that oral route infection of P. multocida type B:2 immunogen lipopolysaccharide can be used to stimulate host cell responses where oral vaccine through feed could be developed in the near future.


Subject(s)
Buffaloes/microbiology , Lipopolysaccharides/immunology , Pasteurella Infections/veterinary , Pasteurella multocida/immunology , Animals , Buffaloes/blood , Buffaloes/immunology , Cattle , Hematology , Pasteurella Infections/blood , Pasteurella Infections/microbiology , Pasteurella Infections/pathology , Pasteurella multocida/pathogenicity , Pasteurella multocida/physiology , Virulence
14.
BMC Vet Res ; 12: 25, 2016 Feb 03.
Article in English | MEDLINE | ID: mdl-26841756

ABSTRACT

BACKGROUND: The objective of this study was to elucidate the pathogenic mechanisms of how Mycoplasma hyopneumoniae enhances secondary Pasteurella multocida type A infection which leads to porcine enzootic pneumonia in infected pigs. Sixteen pigs were experimentally infected with M. hyopneumoniae and then euthanized at 7, 14, 21 and 28 days post inoculation. In situ hybridization for M. hyopneumoniae DNA and Ulex europaeus agglutinin-I (UEA-I) lectin histochemistry for fucosyl glycoconjugate, was performed in serial lung sections to determine alteration of fucosyl glycoconjugate in M. hyopneumoniae-infected bronchial and bronchiolar epithelium. Bacterial overlay assay was performed to determine the affinity of P. multocida type A with L-fucose. RESULTS: The luminal surface of bronchial and bronchiolar epithelial cells that were stained with UEA-I always showed hybridization signals for M. hyopneumoniae but it was negative in the unaffected parts of the lung from M. hyopneumoniae-infected pigs and in lung from negative control pigs. Colocalization of M. hyopneumoniae and UEA-I was especially prominent in the luminal surface of bronchial and bronchiolar epithelial cells in serial section of lung. The mean number of M. hyopneumoniae-positive cells correlated with the mean number of UEA-I-positive cells in lungs from infected pigs throughout the experiment. All eight P. multocida type A isolates from naturally occurring enzootic pneumonia, bound strongly at levels of 2 µg and 5 µg of L-fucose. CONCLUSIONS: The results of the present study demonstrate that M. hyopneumoniae increases the L-fucose composition to enhance adherence of P. multocida type A to the bronchial and bronchiolar epithelial cells.


Subject(s)
Fucose/metabolism , Glycoconjugates/metabolism , Pasteurella Infections/veterinary , Pasteurella multocida/physiology , Pneumonia of Swine, Mycoplasmal/microbiology , Respiratory Mucosa/microbiology , Animals , Bacterial Adhesion , Cilia , Coinfection/veterinary , DNA, Bacterial/analysis , In Situ Hybridization , Pasteurella Infections/microbiology , Plant Lectins , Swine
15.
Cell Commun Signal ; 13: 40, 2015 Sep 14.
Article in English | MEDLINE | ID: mdl-26369790

ABSTRACT

BACKGROUND: Pasteurella multocida toxin (PMT) is a potent inducer of osteoclast formation. Pigs suffering from an infection with toxigenic Pasteurella multocida strains develop atrophic rhinitis characterised by a loss of turbinate bones and conchae. However, on the molecular level the process of bone loss remains largely uncharacterised. RESULTS: Recently it was found that PMT activates the serine/threonine kinase mammalian target of rapamycin (mTOR) in fibroblasts. Using RAW264.7 macrophages, we investigated the role of the mTOR complex 1 (mTORC1) in PMT-mediated osteoclast formation. PMT induces the differentiation of RAW264.7 macrophages into multinucleated, tartrate resistant acid phosphatase (TRAP) positive osteoclasts that are capable to resorb bone. In the presence of the mTORC1 inhibitor rapamycin, PMT was significantly less able to induce the formation of TRAP-positive osteoclasts. Accordingly, the resulting resorption of bone was strongly reduced. A major target of mTOR is the 70 kDa ribosomal protein S6 kinase 1 (p70 S6K1). Activated p70 S6K1 decreases the expression of programmed cell death protein 4 (PDCD4), a negative transcriptional regulator of osteoclastogenesis, at the protein and gene level. Ultimately this results in the activation of c-Jun, a component of the activator protein 1 (AP-1) complex, which is a major transcription factor for the induction of osteoclast-specific genes. We now demonstrate that c-Jun and its downstream target, the osteoclast-specific bone degrading protease cathepsin K, are upregulated upon PMT treatment in an mTOR-dependent manner. CONCLUSIONS: Activation of mTOR signalling plays a central role in the formation of osteoclasts through the bacterial toxin PMT. On the molecular level, PMT-induced activation of mTOR leads to down regulation of PDCD4, a known repressor of AP-1 complex, culminating in the activation of c-Jun, an essential transcription factor for triggering osteoclastogenesis.


Subject(s)
Bacterial Proteins/metabolism , Bacterial Toxins/metabolism , Bone Resorption/veterinary , Macrophages/microbiology , Multiprotein Complexes/metabolism , Osteoclasts/microbiology , Pasteurella Infections/veterinary , Pasteurella multocida/physiology , TOR Serine-Threonine Kinases/metabolism , Animals , Apoptosis Regulatory Proteins/metabolism , Bone Resorption/metabolism , Bone Resorption/microbiology , Bone Resorption/pathology , Cathepsin K/metabolism , Cell Line , Macrophages/metabolism , Macrophages/pathology , Mechanistic Target of Rapamycin Complex 1 , Mice , Osteoclasts/metabolism , Osteoclasts/pathology , Pasteurella Infections/complications , Pasteurella Infections/metabolism , Pasteurella Infections/pathology , Proto-Oncogene Proteins c-jun/metabolism , RNA-Binding Proteins/metabolism , Signal Transduction , Swine , Transcription Factor AP-1/metabolism
16.
Biomarkers ; 20(3): 189-95, 2015.
Article in English | MEDLINE | ID: mdl-26161700

ABSTRACT

CONTEXT: Acute phase proteins (APPs) are proposed as potential markers of the health status in pigs. OBJECTIVE: Circulating APPs in pigs co-infected with swine influenza virus and Pasteurella multocida. METHODS: Serum APPs were measured in co-infected and control pigs with the use of commercial ELISA tests. RESULTS: All investigated APPs revealed significant changes in co-infected pigs during the study period. The concentration of C-reactive protein, haptoglobin and serum amyloid A (SAA) increased significantly at 2 dpi, before respiratory signs and fever were observed. Concentration of Pig-MAP increased significantly at 3 dpi. C-reactive protein and SAA reaction were rapid but short-lived. The concentration of Hp and Pig-MAP in serum also increased at very early stage of co-infection but remained elevated for a longer period of time. CONCLUSIONS: Maximal concentration of serum amyloid A correlated with the disease severity in pigs.


Subject(s)
Lung/metabolism , Orthomyxoviridae Infections/diagnosis , Orthomyxoviridae Infections/veterinary , Pasteurella Infections/diagnosis , Swine Diseases/diagnosis , Acute-Phase Proteins/metabolism , Animals , Biomarkers/blood , C-Reactive Protein/metabolism , Case-Control Studies , Coinfection , Enzyme-Linked Immunosorbent Assay , Haptoglobins/metabolism , Influenza A Virus, H3N2 Subtype/pathogenicity , Influenza A Virus, H3N2 Subtype/physiology , Lung/microbiology , Lung/pathology , Lung/virology , Orthomyxoviridae Infections/blood , Orthomyxoviridae Infections/virology , Pasteurella Infections/blood , Pasteurella Infections/microbiology , Pasteurella Infections/pathology , Pasteurella multocida/pathogenicity , Pasteurella multocida/physiology , Serum Amyloid A Protein/metabolism , Severity of Illness Index , Swine , Swine Diseases/blood , Swine Diseases/microbiology , Swine Diseases/virology
17.
Clin Microbiol Rev ; 26(3): 631-55, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23824375

ABSTRACT

In a world where most emerging and reemerging infectious diseases are zoonotic in nature and our contacts with both domestic and wild animals abound, there is growing awareness of the potential for human acquisition of animal diseases. Like other Pasteurellaceae, Pasteurella species are highly prevalent among animal populations, where they are often found as part of the normal microbiota of the oral, nasopharyngeal, and upper respiratory tracts. Many Pasteurella species are opportunistic pathogens that can cause endemic disease and are associated increasingly with epizootic outbreaks. Zoonotic transmission to humans usually occurs through animal bites or contact with nasal secretions, with P. multocida being the most prevalent isolate observed in human infections. Here we review recent comparative genomics and molecular pathogenesis studies that have advanced our understanding of the multiple virulence mechanisms employed by Pasteurella species to establish acute and chronic infections. We also summarize efforts being explored to enhance our ability to rapidly and accurately identify and distinguish among clinical isolates and to control pasteurellosis by improved development of new vaccines and treatment regimens.


Subject(s)
Pasteurella Infections/microbiology , Pasteurella multocida/physiology , Zoonoses/microbiology , Animals , Host-Pathogen Interactions , Humans , Virulence
18.
BMC Vet Res ; 10: 88, 2014 Apr 11.
Article in English | MEDLINE | ID: mdl-24721163

ABSTRACT

BACKGROUND: Haemorrhagic septicaemia (HS) is an acute septicaemic disease of buffalo and cattle caused by Pasteurella multocida B:2 and E:2. Field outbreaks of HS are known to result in localisation of bacteria in the tonsils of surviving buffalo, confirming that animals can become carriers and the role of respiratory tract in the transmission of the disease. This report describes additional sites of localisation of P. multocida B:2 in surviving buffalo following experimental induction of HS. RESULTS: Following P. multocida B:2 infection, all calves in group 1 and one calf in group 2 that was allowed to commingle with infected calves from group 1 were euthanised within 48 h. Pasteurella multocida B:2 was detected from the nasal and rectal swab samples on days 5 and 6 from the remaining calves in group 2. The first injection of dexamethasone into the carrier animals resulted in reemergence in samples from the nose, rectum and vagina. However, subsequent dexamethasone injections failed to re-activate P. multocida B:2. When surviving carrier calves in group 2 were euthanised at the end of the experiment, P. multocida B:2 was detected in the lungs and various organs of the respiratory, gastrointestinal and urinary tracts. CONCLUSIONS: Commingling naive buffalo calves with calves acutely infected with P. multocida B:2 resulted in carriers among surviving buffalo. Pasteurella was found in various organs of the respiratory, gastrointestinal and urinary tracts, suggesting their role in the pathogenesis of HS.


Subject(s)
Buffaloes/microbiology , Hemorrhagic Septicemia/veterinary , Pasteurella multocida , Animals , Carrier State/microbiology , Carrier State/veterinary , Hemorrhagic Septicemia/microbiology , Hemorrhagic Septicemia/pathology , Immunoenzyme Techniques/veterinary , Pasteurella multocida/isolation & purification , Pasteurella multocida/physiology
19.
Pol J Microbiol ; 62(4): 435-8, 2013.
Article in English | MEDLINE | ID: mdl-24730139

ABSTRACT

Prosthetic joint infections due to Pasteurella multocida are rarely but increasingly reported but no data on production of biofilm are available. We report the case of a woman with a late, haematogenous peri-prosthetic infection of cemented total knee arthroplasty caused by a strain of P. multocida identified by pyrosequencing and unable to produce biofilm. Comparison of clinical and laboratory findings with those reported in other patients evidenced differences mainly in the period of symptoms' onset and in the behaviour of some inflammatory markers.


Subject(s)
Biofilms , Pasteurella Infections/microbiology , Pasteurella multocida/classification , Pasteurella multocida/physiology , Prosthesis-Related Infections/microbiology , Aged, 80 and over , Female , Humans , Nucleic Acid Amplification Techniques , Pasteurella Infections/surgery , Prosthesis-Related Infections/surgery
20.
Wei Sheng Wu Xue Bao ; 53(1): 66-73, 2013 Jan 04.
Article in Zh | MEDLINE | ID: mdl-23614242

ABSTRACT

OBJECTIVE: To study the role of the outer membrane protein H (OmpH) in pathogenicity of avian Pasteurella multocida. METHODS: The ompH knock-out mutant of avian P. multocida C48-3 was constructed by homologous recombination. The DNA replacement was confirmed by PCR, RT-PCR and Western blot. We compared the differences of biological characteristics such as growth rate, capsular structure, adhesion ability and virulence between the ompH knockout mutant of C48-3 Delta ompH and parent strain C48-3, as well as the complemented strain C48-3C. RESULTS: C48-3 Delta ompH was successfully constructed. Electron microscopy examination of C48-3 Delta ompH shows the absence of capsular material compared to the parent strain C48-3 and complemented strain C48-3C. The adhesion assay shows that the number of C48-3 Delta ompH adhered to CEF cells was significantly lower than that of C48-3 and C48-3C. C48-3 Delta ompH was relatively attenuated in mice by intraperitoneal injection. CONCLUSION: The construction of C48-3 Delta ompH would facilitate further study on pathogenesis of avian Pasteurella multocida.


Subject(s)
Bacterial Outer Membrane Proteins/genetics , Pasteurella multocida/genetics , Pasteurella multocida/pathogenicity , Poultry Diseases/microbiology , Animals , Bacterial Adhesion , Bacterial Outer Membrane Proteins/metabolism , Chick Embryo , Female , Gene Knockout Techniques , Mice , Mice, Inbred BALB C , Pasteurella multocida/physiology , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL